Introduction: Advanced cutaneous squamous cell carcinoma (cSCC) is associated with a poor prognosis. Although anti-PD1 immunotherapy has improved cSCC management, its efficacy remains limited in some patients. Second-line options... ...

请注册登录后继续浏览